Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05836649 · ClinicalTrials.gov registry record · NA

Impact of Passive VR Versus Active VR on Heat Pain Thresholds and Pressure Pain Thresholds

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
265
Enrollment target

NCT05836649: Completed NA study, sponsored by Stanford University.

NCT05836649 is a NA study that has completed, run by Stanford University. The registered enrollment target is 265 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05836649, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
265 participants
Enrollment target

Study Summary

This is a prospective, crossover study of healthy participants evaluating the impact of passive vs. active virtual reality (VR) games on heat pain threshold (HPT) and pressure pain threshold (PPT).

Primary Outcome

Heat pain threshold measured by the TSA Air II device. Temperature ranges from 32 degrees C to 50 degrees C, with higher temperatures indicating a higher heat pain threshold.

Interventions

  • BEHAVIORAL Oculus Go headset without active intervention
  • BEHAVIORAL Oculus Go headset with active intervention
  • BEHAVIORAL Oculus Go headset without immersive virtual reality experience
  • BEHAVIORAL Oculus Go headset with immersive virtual reality experience

Trial Details

FieldValue
Enrollment Target 265 participants
Start Date 2023-08-04
Est. Completion 2024-01-03
Phase NA
Stanford University

1,744 total trials

What the finished NCT05836649 record still lists

NCT05836649 is an interventional study that assigns participants to a tested intervention. The registered 265 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 4 interventions - of which Oculus Go headset without active intervention is the first listed.

NCT05836649 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05836649 about?

NCT05836649 is a clinical study titled "Impact of Passive VR Versus Active VR on Heat Pain Thresholds and Pressure Pain Thresholds". This is a prospective, crossover study of healthy participants evaluating the impact of passive vs. active virtual reality (VR) games on heat pain threshold (HPT) and pressure pain threshold (PPT).

What is the current status of trial NCT05836649?

This trial is currently completed. It is a NA study. The enrollment target is 265 participants. The study started on 2023-08-04. Estimated completion is 2024-01-03.

What interventions are being tested in trial NCT05836649?

The interventions under investigation include: Oculus Go headset without active intervention (BEHAVIORAL), Oculus Go headset with active intervention (BEHAVIORAL), Oculus Go headset without immersive virtual reality experience (BEHAVIORAL), Oculus Go headset with immersive virtual reality experience (BEHAVIORAL).

Who is sponsoring clinical trial NCT05836649?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05836649's enrollment target sits among peer trials

265 395th of 2000 higher than 1,606 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05443126 · 265 participants · Phase 1

    A Study of EP0031 in Patients With Advanced RET-altered Malignancies

  • NCT05470491 · 265 participants · Phase 1

    Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

  • NCT07301905 · 265 participants · NA

    Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI

  • NCT07470853 · 265 participants · Phase 1

    A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05836649, the US trial registry maintained by the National Library of Medicine. NCT05836649 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.